122 related articles for article (PubMed ID: 37227775)
1. Visible-light promoted catalyst-free (VLCF) multi-component synthesis of spiro indolo-quinazolinone-pyrrolo[3,4-a]pyrrolizine hybrids: evaluation of
Iqbal S; Farhanaz ; Roohi ; Zaheer MR; Shankar K; Hussain MK; Zia Q; Rehman MT; AlAjmi MF; Gupta A
J Biomol Struct Dyn; 2024 Apr; 42(6):3145-3165. PubMed ID: 37227775
[TBL] [Abstract][Full Text] [Related]
2. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
[TBL] [Abstract][Full Text] [Related]
3. Isolation and biological evaluation 7-hydroxy flavone from
Parthiban A; Sachithanandam V; Lalitha P; Elumalai D; Asha RN; Jeyakumar TC; Muthukumaran J; Jain M; Jayabal K; Mageswaran T; Sridhar R; Purvaja R; Ramesh R
J Biomol Struct Dyn; 2023 Apr; 41(7):2848-2860. PubMed ID: 35193476
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
[TBL] [Abstract][Full Text] [Related]
5. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation,
Bimoussa A; Fawzi M; Oubella A; Ejaz SA; Sajjad Bilal M; Labd Taha M; Auhmani A; Morjani H; Robert A; Riahi A; Ait Itto MY
J Biomol Struct Dyn; 2023; 41(21):11987-11999. PubMed ID: 36617941
[TBL] [Abstract][Full Text] [Related]
6. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel (
Riadi Y; Afzal O; Kumar S; Varadharajan V; Geesi MH
J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38523573
[TBL] [Abstract][Full Text] [Related]
8. In-vitro anticancer evaluation of newly designed and characterized tri/tetra-substituted imidazole congeners- maternal embryonic leucine zipper kinase inhibitors: Molecular docking and MD simulation approaches.
Mahapatra M; Mohapatra P; Pakeeraiah K; Bandaru RK; Ahmad I; Mal S; Dandela R; Sahoo SK; Patel H; Paidesetty SK
Int J Biol Macromol; 2023 Sep; 249():126084. PubMed ID: 37532192
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, biological evaluation and molecular docking of a new quinazolinone-based derivative as a potent dual inhibitor for VEGFR-2 and EGFR tyrosine kinases.
Riadi Y; Alamri MA; Geesi MH; Anouar EH; Ouerghi O; Alabbas AB; Alossaimi MA; Altharawi A; Dehbi O; Alqahtani SM
J Biomol Struct Dyn; 2022 Sep; 40(15):6810-6816. PubMed ID: 33682611
[TBL] [Abstract][Full Text] [Related]
10. Exploration of interaction behavior between spiro[indene-2,2'-[1,3,5]oxathiazine]-1,3-diones and DNA with the help of DFT, molecular docking, and MD simulations.
Salehpour M; Azizian J
J Biomol Struct Dyn; 2022; 40(19):9194-9213. PubMed ID: 33998964
[TBL] [Abstract][Full Text] [Related]
11. Regio- and stereoselective synthesis of new spirooxindoles via 1,3-dipolar cycloaddition reaction: Anticancer and molecular docking studies.
Lotfy G; El Ashry ESH; Said MM; El Tamany ES; Abdel Aziz YM; Al-Dhfyan A; Al-Majid AM; Barakat A
J Photochem Photobiol B; 2018 Mar; 180():98-108. PubMed ID: 29413708
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolizine/Indolizine-NSAID Hybrids: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies.
Abourehab MAS; Alqahtani AM; Almalki FA; Zaher DM; Abdalla AN; Gouda AM; Beshr EAM
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770990
[TBL] [Abstract][Full Text] [Related]
13. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
Paul M; Kumar Panda M; Thatoi H
J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
[TBL] [Abstract][Full Text] [Related]
14. In silico and in vitro evaluation of newly synthesized pyrazolo-pyridine fused tetrazolo-pyrimidines derivatives as potential anticancer and antimicrobial agents.
Patel HC; Patel MS; Parekh JN; Chudasama DD; Dalwadi P; Kunjadiya A; Bhatt V; Modi KM; Patel CN; Ram KR
J Biomol Struct Dyn; 2023 Dec; ():1-24. PubMed ID: 38146736
[TBL] [Abstract][Full Text] [Related]
15. In Silico and In Vitro Evaluations of Fluorophoric Thiazolo-[2,3-b]quinazolinones as Anti-cancer Agents Targeting EGFR-TKD.
Mir SA; Dash GC; Meher RK; Mohanta PP; Chopdar KS; Mohapatra PK; Baitharu I; Behera AK; Raval MK; Nayak B
Appl Biochem Biotechnol; 2022 Oct; 194(10):4292-4318. PubMed ID: 35366187
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
[TBL] [Abstract][Full Text] [Related]
17. Discovery, synthesis and
Saravana Mani K; Rajamanikandan S; Prabha B
J Biomol Struct Dyn; 2023; 41(22):13454-13465. PubMed ID: 36744520
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, anticancer and
Alshammari MM; Soury R; Alenezi KM; Mushtque M; Rizvi MMA; Haque A
J Biomol Struct Dyn; 2022; 40(23):13075-13082. PubMed ID: 34551668
[TBL] [Abstract][Full Text] [Related]
19. Identification of Spiro-Fused Pyrrolo[3,4-
Latypova DK; Shmakov SV; Pechkovskaya SA; Filatov AS; Stepakov AV; Knyazev NA; Boitsov VM
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769424
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors.
Ali IH; Abdel-Mohsen HT; Mounier MM; Abo-Elfadl MT; El Kerdawy AM; Ghannam IAY
Bioorg Chem; 2022 Sep; 126():105883. PubMed ID: 35636123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
